Journal of Cardiovascular Computed Tomography
Volume 3, Issue 1, Supplement , Pages S2-S12 , January 2009

Evaluation of myocardial viability by multidetector CT

Received 24 June 2008 ,Accepted 1 October 2008.

References 

  1. Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation. 1979;59:421–430
  2. Harris PJ, Harrell FE, Lee KL, Behar VS, Rosati RA. Survival in medically treated coronary artery disease. Circulation. 1979;60:1259–1269
  3. Mock MB, Ringqvist I, Fisher LD, Davis KB, Chaitman BR, Kouchoukos NT, et al. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1982;66:562–568
  4. Muhlbaier LH, Pryor DB, Rankin JS, Smith LR, Mark DB, Jones RH, et al. Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. 20 years of follow-up. Circulation. 1992;86(5 Suppl):II198–II204
  5. Emond M, Mock MB, Davis KB, Fisher LD, Holmes DR, Chaitman BR, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645–2657
  6. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146–1149
  7. Wijns W, Vatner SF, Camici PG. Mechanisms of disease: hibernating myocardium. N Engl J Med. 1998;339:173–181
  8. Rahimtoola SH. Coronary bypass surgery for chronic angina–1981: a perspective. Circulation. 1982;65:225–241
  9. Ross JJ. Myocardial perfusion-contraction matching: implications for coronary artery disease and hibernation. Circulation. 1991;83:1076–1083
  10. Bonow RO. Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1159–1162
  11. Gersh BJ, Anderson JL. Thrombolysis and myocardial salvage. Results of clinical trials and the animal paradigm–paradoxic or predictable?. Circulation. 1993;88:296–306
  12. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151–1158
  13. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374–379
  14. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995;91:663–670
  15. Hamdan A, Zafrir N, Sagie A, Kornowski R. Modalities to assess myocardial viability in the modern cardiology era. Coron Artery Dis. 2006;17:567–576
  16. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation. 1995;92:1902–1910
  17. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992–2002
  18. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol. 2000;36:1985–1991
  19. Dendale P, Franken PR, Holman E, Avenarius J, van der Wall EE, de Roos A. Validation of low-dose dobutamine magnetic resonance imaging for assessment of myocardial viability after infarction by serial imaging. Am J Cardiol. 1998;82:375–377
  20. Sandstede JJW, Bertsch G, Beer M, Kenn W, Werner E, Pabst T, et al. Detection of myocardial viability by low-dose dobutamine cine MR imaging. Magn Reson Imaging. 1999;17:1437–1443
  21. Wellnhofer E, Olariu A, Klein C, Grafe M, Wahl A, Fleck E, et al. Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation. 2004;109:2172–2174
  22. Kim RJ, Wu EW, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–1453
  23. Wu KC, Lima JAC. Noninvasive imaging of myocardial viability: current techniques and future developments. Circ Res. 2003;93:1146–1158
  24. Adams DF, Hessel SJ, Judy PF, Stein JA, Abrams HL. Differing attenuation coefficients of normal and infarcted myocardium. Science. 1976;192:467–469
  25. Higgins CB, Sovak M, Schmidt W, Siemers PT. Uptake of contrast materials by experimental acute myocardial infarctions: a preliminary report. Invest Radiol. 1978;23(Suppl):S271–S274
  26. Huber DJ, Lapray JF, Hessel SJ. In vivo evaluation of experimental myocardial infarcts by ungated computed tomography. AJR Am J Roentgenol. 1981;136:469–473
  27. Kramer PH, Goldstein JA, Herkens RJ, Lipton MJ, Brundage BH. Imaging of acute myocardial infarction in man with contrast-enhanced computed transmission tomography. Am Heart J. 1984;108:1514–1523
  28. Wittenberg J, Powell WMJ, Dinsmore RE, Miller SW, Maturi RA. Computerized tomography of ischemic myocardium: quantitation of extent and severity of edema in an in vitro canine model. Invest Radiol. 1977;12:215–223
  29. Siemers PT, Higgins CB, Schmidt W, Ashburn W, Hagan P. Detection, quantitation and contrast enhancement of myocardial infarction utilizing computerized axial tomography: comparison with histochemical staining and 99mTc-pyrophosphate imaging. Invest Radiol. 1978;13:103–109
  30. Adams DF, Hessel SJ, Judy PF, Stein JA, Abrams H. Computed tomography of the normal and infarcted myocardium. AJR Am J Roentgenol. 1976;126:786–791
  31. Higgins CB, Siemers PT, Schmidt W, Newell JD. Evaluation of myocardial ischemic damage of various ages by computerized transmission tomography: time-dependent effects of contrast material. Circulation. 1979;60:284–291
  32. Higgins CB, Sovak M, Schmidt W, Siemers PT. Differential accumulation of radiopaque contrast material in acute myocardial infarction. Am J Cardiol. 1979;43:47–51
  33. Powell WMJ, Wittenberg J, Maturi RA, Dinsmore RE, Miller SW. Detection of edema associated with myocardial ischemia by computerized tomography in isolated, arrested canine hearts. Circulation. 1977;55:99–108
  34. Ter-Pogossian MM, Weiss ES, Coleman RE, Sobel BE. Computed tomography of the heart. AJR Am J Roentgenol. 1976;127:79–90
  35. Alfidi RJ, Mac Intyre WJ, Haaga JR. The effects of biological motion on CT resolution. AJR Am J Roentgenol. 1976;127:11–15
  36. Harell GS, Guthaner DF, Breiman RS, Morehouse CC, Seppi EJ, Marshall WH, et al. Stop-action cardiac computed tomography. Radiology. 1977;123:515–517
  37. Kalra MK, Brady TJ. Current status and future directions in technical developments of cardiac computed tomography. J Cardiovasc Comput Tomogr. 2008;2:71–80
  38. Gray WR, Buja LM, Hagler HK, Parkey RW, Willerson JT. Computed tomography for localization and sizing of experimental acute myocardial infarcts. Circulation. 1978;58:497–504
  39. Doherty PW, Lipton MJ, Berninger WH, Skioldebrand CG, Carlsson E, Redington RW. Detection and quantitation of myocardial infarction in vivo using transmission computed tomography. Circulation. 1981;63:597–606
  40. Georgiou D, Bleiweis M, Brundage BH. Conventional and ultrafast computed tomography in the detection of viable versus infarcted myocardium. Am J Card Imaging. 1992;6:228–236
  41. Hoffmann U, Millea R, Enzweiler C, Ferencik M, Gulick S, Titus J, et al. Acute myocardial infarction: contrast-enhanced multi-detector row CT in a porcine model. Radiology. 2004;231:697–701
  42. Nikolaou K, Knez A, Sagmeister S, Wintersperger BJ, Boekstegers P, Steinbeck G, et al. Assessment of myocardial infarctions using multidetector-row computed tomography. J Comput Assist Tomogr. 2004;28:286–292
  43. Nieman K, Cury RC, Ferencik M, Nomura CH, Abbara S, Hoffmann U, et al. Differentiation of recent and chronic myocardial infarction by cardiac computed tomography. Am J Cardiol. 2006;98:303–308
  44. Francone M, Carbone I, Danti M, Lanciotti K, Cavacece M, Mirabelli F, et al. ECG-gated multi-detector row spiral CT in the assessment of myocardial infarction: correlation with non-invasive angiographic findings. Eur Radiol. 2006;16:15–24
  45. Nikolaou K, Sanz J, Poon M, Wintersperger BJ, Ohnesorge B, Rius T, et al. Assessment of myocardial perfusion and viability from routine contrast-enhanced 16-detector-row computed tomography of the heart: preliminary results. Eur Radiol. 2005;15:864–871
  46. Sanz J, Weeks D, Nikolaou K, Sirol M, Rius T, Rajagopalan S, et al. Detection of healed myocardial infarction with multidetector-row computed tomography and comparison with cardiac magnetic resonance delayed hyperenhancement. Am J Cardiol. 2006;98:149–155
  47. Henneman MM, Schuijf JD, Jukema JW, Lamb HJ, de Roos A, Dibbets P, et al. Comprehensive cardiac assessment with multislice computed tomography: evaluation of left ventricular function and perfusion in addition to coronary anatomy in patients with previous myocardial infarction. Heart. 2006;92:1779–1783
  48. Henneman MM, Schuijf JD, Dibbets-Schneider P, Stokkel MP, van der Geest JR, van der Wall EE, et al. Comparison of multislice computed tomography to gated single-photon emission computed tomography for imaging of healed myocardial infarcts. Am J Cardiol. 2008;101:144–148
  49. Kurata A, Mochizuki T, Koyama Y, Haraikawa T, Suzuki J, Shigematsu Y, et al. Myocardial perfusion imaging using adenosine triphosphate stress multi-slice spiral computed tomography: alternative to stress myocardial perfusion scintigraphy. Circ J. 2005;69:550–557
  50. Jennings RB, Murry CE, Steenbergen CJ, Reimer KA. Development of cell injury in sustained acute ischemia. Circulation. 1990;82(3 Suppl):II2–II12
  51. Jennings RB, Schaper J, Hill ML, Steenbergen CJ, Reimer KA. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res. 1985;56:262–278
  52. Lima JAC, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Circulation. 1995;92:1117–1125
  53. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26:1461–1474
  54. Gerber BL, Belge B, Legros GJ, Lim P, Poncelet A, Pasquet A, et al. Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation. 2006;113:823–833
  55. Buecker A, Katoh M, Krombach GA, Spuentrup E, Bruners P, Gunther RW, et al. A feasibility study of contrast enhancement of acute myocardial infarction in multislice computed tomography: comparison with magnetic resonance imaging and gross morphology in pigs. Invest Radiol. 2005;40:700–704
  56. Lardo AC, Cordeiro MAS, Silva C, Amado LC, George RT, Saliaris AP, et al. Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation. 2006;113:394–404
  57. Baks T, Cademartiri F, Moelker AD, van der Giessen WJ, Krestin GP, Duncker JD, et al. Assessment of acute reperfused myocardial infarction with delayed enhancement 64-MDCT. AJR Am J Roentgenol. 2007;188:W135–W137
  58. Baks T, Cademartiri F, Moelker AD, Weustink AC, van Geuns RJ, Mollet NR, et al. Multislice computed tomography and magnetic resonance imaging for the assessment of reperfused acute myocardial infarction. J Am Coll Cardiol. 2006;48:144–152
  59. Mahnken AH, Bruners P, Kinzel S, Katoh M, Muhlenbruch G, Gunther RW, et al. Late-phase MSCT in the different stages of myocardial infarction: animal experiments. Eur Radiol. 2007;17:2130–2137
  60. Mahnken AH, Koos R, Katoh M, Wildberger JE, Spuentrup E, Buecker A, et al. Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol. 2005;45:2042–2047
  61. Cury RC, Nieman K, Shapiro MD, Nasir K, Cury RC, Brady TJ. Comprehensive cardiac CT study: evaluation of coronary arteries, left ventricular function, and myocardial perfusion–Is it possible?. J Nucl Cardiol. 2007;14:229–243
  62. Choe YH, Choo KS, Jeon ES, Gwon HC, Choi JH, Park JE. Comparison of MDCT and MRI in the detection and sizing of acute and chronic myocardial infarcts. Eur J Radiol. 2008;66:292–299
  63. Habis M, Capderou A, Ghostine S, Daoud B, Caussin C, Riou JY, et al. Acute myocardial infarction early viability assessment by 64-slice computed tomography immediately after coronary angiography: comparison with low-dose dobutamine echocardiography. J Am Coll Cardiol. 2007;49:1178–1185
  64. Chiou KR, Liu CP, Peng NJ, Huang WC, Hsiao SH, Huang YL, et al. Identification and viability assessment of infarcted myocardium with late enhancement multidetector computed tomography: comparison with thallium single photon emission computed tomography and echocardiography. Am Heart J. 2008;155:738–745
  65. Wada H, Kobayashi Y, Yasu T, Tsukamoto Y, Kobayashi N, Ishida T, et al. Multi-detector computed tomography for imaging of subendocardial infarction: prediction of wall motion recovery after reperfused anterior myocardial infarction. Circ J. 2004;68:512–514
  66. Koyama Y, Matsuoka H, Mochizuki T, Higashino H, Kawakami H, Nakata S, et al. Assessment of reperfused acute myocardial infarction with two-phase contrast-enhanced helical CT: prediction of left ventricular function and wall thickness. Radiology. 2005;235:804–811
  67. Lessick J, Dragu R, Mutlak D, Rispler S, Beyar R, Litmanovich D, et al. Is functional improvement after myocardial infarction predicted with myocardial enhancement patterns at multidetector CT?. Radiology. 2007;244:736–744
  68. Mahnken AH, Bruners P, Muhlenbruch G, Emmerich M, Hohl C, Gunther RW, et al. Low tube voltage improves computed tomography imaging of delayed myocardial contrast enhancement in an experimental acute myocardial infarction model. Invest Radiol. 2007;42:123–129
  69. Brodoefel H, Klumpp B, Reimann A, Ohmer M, Fenchel M, Schroeder S, et al. Late myocardial enhancement assessed by 64-MSCT in reperfused porcine myocardial infarction: diagnostic accuracy of low-dose CT protocols in comparison with magnetic resonance imaging. Eur Radiol. 2007;17:475–483
  70. Brodoefel H, Reimann A, Klumpp B, Fenchel M, Ohmer M, Miller S, et al. Assessment of myocardial viability in a reperfused porcine model: evaluation of different MSCT contrast protocols in acute and subacute infarct stages in comparison with MRI. J Comput Assist Tomogr. 2007;31:290–298
  71. Ruzsics B, Suranyi P, Kiss P, Brott BC, Singh SS, Litovsky S, et al. Automated multidetector computed tomography evaluation of subacutely infarcted myocardium. J Cardiovasc Comput Tomogr. 2008;2:26–32
  72. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, et al. Occluded Artery Trial Investigators: Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355:2395–2407
  73. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. COURAGE Trail Research Group: Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–1516
  74. Dzavik V, Buller CE, Lamas GA, Rankin JM, Mancini GB, Cantor WJ, et al. TOSCA-2 Investigators: Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function. The Total Occlusion Study of Canada (TOSCA)-2 Trial. Circulation. 2006;114:2449–2457
  75. Baks T, van Geuns RJ, Duncker DJ, Cademartiri F, Mollet NR, Krestin GP, et al. Prediction of left ventricular function after drug-eluting stent implantation for chronic total coronary occlusions. J Am Coll Cardiol. 2006;47:721–725
  76. Kirschbaum SW, Baks T, van den Ent M, Sianos G, Krestin GP, Serruys PW, et al. Evaluation of left ventricular function three years after percutaneous recanalization of chronic total occlusions. Am J Cardiol. 2008;101:179–185
  77. Kloner RA, Ganote CE, Jennings RB. The “no-reflow” phenomenon after temporary coronary occlusion in the dog. J Clin Invest. 1974;54:1496–1508
  78. Baks T, van Geuns RJ, Biagini E, Wielopolski P, Mollet NR, Cademartiri F, et al. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics. J Am Coll Cardiol. 2006;47:40–44
  79. Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoher M, Kochs M, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J. 2005;26:549–557
  80. Tarantini G, Razzolini R, Cacciavillani L, Bilato C, Sarais C, Corbetti F, et al. Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty. Am J Cardiol. 2006;98:1033–1040
  81. Rogers WJ, Kramer CM, Geskin G, Hu YL, Theobald TM, Vido DA, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation. 1999;99:744–750
  82. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765–772
  83. Kramer CM. The prognostic significance of microvascular obstruction after myocardial infarction as defined by cardiovascular magnetic resonance. Eur Heart J. 2005;26:532–533
  84. Brodoefel H, Klumpp B, Reimann A, Fenchel M, Heuschmid M, Miller S, et al. Sixty-four-MSCT in the characterization of porcine acute and subacute myocardial infarction: determination of transmurality in comparison to magnetic resonance imaging and histopathology. Eur J Radiol. 2007;62:235–246
  85. McCrohon JA, Moon JCC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–59
  86. Dambrin G, Laissy JP, Serfaty JM, Caussin C, Lancelin B, Paul JF. Diagnostic value of ECG-gated multidetector computed tomography in the early phase of suspected acute myocarditis. A preliminary comparative study with cardiac MRI. Eur Radiol. 2007;17:331–338
  87. Kanao S, Tadamura E, Yamamuro M, Kubo S, Kmura T, Kita T, et al. Demonstration of cardiac involvement of sarcoidosis by contrast-enhanced multislice computed tomography and delayed-enhanced magnetic resonance imaging. J Comput Assist Tomogr. 2005;29:745–748
  88. Moon JCC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol. 2003;41:1561–1567
  89. Blyth KG, Groenning BA, Martin TN, Foster JE, Mark PB, Dargie HJ, et al. Contrast enhanced-cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J. 2005;26:1993–1999
  90. Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186–193

 Conflict of interest: The author reports no conflicts of interest.

PII: S1934-5925(08)00705-3

doi: 10.1016/j.jcct.2008.10.015

Journal of Cardiovascular Computed Tomography
Volume 3, Issue 1, Supplement , Pages S2-S12 , January 2009

Article Tools

* Image Usage & Resolution